相关实验视频
Updated: Feb 24, 2026

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
21.4K
一个定制的Fanconi贫血的表型概况:解决现有疾病注释中的差距
medRxiv : the preprint server for health sciences
|February 23, 2026
概括
芬科尼贫血 (FA) 诊断得到了新的,全面的人类表型本体学 (HPO) 概况的改进. 这种使用人工智能和专家审查创建的增强型个人资料显著扩展了FA表型数据,以更好地进行临床识别.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 生物信息学是一种生物信息学.
- 医疗信息学 医疗信息学
背景情况:
- 芬科尼贫血 (FA) 是一种罕见的遗传疾病,影响DNA修复,导致骨髓衰竭,出生缺陷和癌症.
- 准确的FA早期诊断对于患者管理至关重要,但由于不完整和不一致的表型数据而受到挑战.
- 在主要数据库中对FA的现有HPO注释显示出显著的不一致性和有限的覆盖范围.
研究的目的:
- 在OMIM和Orphanet数据库中对FA进行现有的HPO注释进行比较.
- 为FA开发一个全面的,人工智能辅助的HPO配置文件,以解决已识别的数据缺口.
- 改进临床决策支持和可计算的表型为FA诊断.
主要方法:
- 在OMIM和Orphanet中对FA的HPO术语进行比较分析.
- 从Fanconi癌症基金会 (FCF) 临床护理指南中提取表型术语,使用一个大型语言模型 (LLM) 工具OntoGPT.
- 手动策划提取的术语以获得准确性和临床相关性,以创建定制的FA HPO配置文件.
主要成果:
- OMIM和Orphanet在285个独特的HPO术语中只有36个 (12.6%) 是共享的,这表明存在很大的分歧.
- 定制的FA HPO配置文件包含264个独特的术语,其中161个 (61.0%) 是新鲜的,并且不在OMIM或Orphanet中.
- 新的术语显著提高了肌肉骨,生殖尿道,四肢,头和消化系统的表型覆盖率.
结论:
- 社区策划的表型特征,特别是当人工智能协助时,可以大幅增加现有的疾病注释.
- 开发的FA HPO概况是迄今为止最全面的,为改善FA诊断提供了基础.
- 该LLM辅助的方法提供了一个可通用的方法,以提高罕见疾病的诊断和减少诊断旅程.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29
Genome-wide Association Studies-GWAS
15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.9K

